Introduction: Who Should Seek Diagnostic Testing

If you or your child begin experiencing changes in vision, particularly during childhood or the teenage years, it is important to see an eye doctor. Stargardt disease often first becomes noticeable when young people have difficulty reading, notice blurry or distorted areas in the center of their vision, or find it harder to see fine details that were once clear. Some children may struggle to adapt when moving between bright and dark environments, such as walking from sunlight into a dimly lit room. Others might notice that colors appear less vibrant or that they need more light than usual to see clearly.^[1][2]

Because Stargardt disease is a genetic condition—meaning it is passed down through families—anyone with a family history of early vision loss or macular problems should be particularly alert to changes in their eyesight. Most people with Stargardt disease first notice symptoms between the ages of 6 and 12, though some individuals do not experience vision problems until adulthood. This makes regular eye examinations especially important for children and young adults who report any difficulty with their central vision.^[3][4]

Early diagnosis matters because even though there is currently no treatment to reverse the damage caused by Stargardt disease, knowing you have the condition allows you to take protective steps that may slow vision loss. It also gives families time to access support services, plan for educational needs, and connect with others who understand what living with this condition means. If you notice gray, black, or hazy spots appearing in the center of your vision, increased sensitivity to light, or challenges with seeing in dim lighting, these are all reasons to schedule an appointment with an eye care professional.^[1][7]

Classic Diagnostic Methods

The Dilated Eye Exam

The foundation of diagnosing Stargardt disease is a comprehensive dilated eye exam. During this examination, your eye doctor will place special drops into your eyes to widen (dilate) your pupils. This allows the doctor to see deep inside your eye and examine your retina and macula—the light-sensitive tissue at the back of your eye. The exam itself is straightforward and does not cause pain. The doctor will look for characteristic signs of Stargardt disease, particularly yellowish flecks or spots on the macula. These flecks are deposits of a fatty material called lipofuscin, which builds up abnormally in people with this condition.^[1][2]

The presence of these yellowish flecks is one of the hallmark features that helps doctors identify Stargardt disease. In many cases, an experienced eye doctor can detect these deposits simply by examining the retina during the dilated exam. The flecks may appear scattered across the macula and sometimes extend to surrounding areas of the retina. As the disease progresses, these areas may change in appearance, and the doctor will be able to track how the condition is developing over time.^[3][7]

Imaging Tests of the Retina

Fundus photography is a specialized technique where your eye doctor takes detailed photographs of your retina. These images capture the yellowish flecks on your macula and provide a permanent record that can be compared during future visits. This helps the doctor monitor whether the disease is progressing and how quickly changes are occurring. Some centers use a variation called fundus autofluorescent photography, which is particularly good at showing the lipofuscin deposits because they naturally emit a faint glow under certain types of light.^[1][2]

Optical coherence tomography, commonly called OCT, is another important diagnostic tool. This test uses light waves to create extremely detailed cross-sectional images of your retina, almost like taking a slice through it to see all the layers. OCT is completely painless and non-invasive. It shows the doctor how thick your retina is and whether any layers have become damaged or thin. In Stargardt disease, OCT can reveal changes in the structure of the macula and the retinal pigment epithelium (RPE), which is a layer of cells that supports the light-sensitive photoreceptor cells.^[1][7]

Some doctors may also use fluorescein angiography, though this test is less commonly needed. During this procedure, a special dye is injected into a vein in your arm. As the dye travels through the blood vessels in your retina, a camera takes rapid photographs. This helps the doctor see the pattern of blood flow and identify any abnormalities in the retinal blood vessels or signs of damage that might not be visible through other methods.^[2][7]

Functional Tests of the Retina

Electroretinography, abbreviated as ERG, is a test that measures how well your retina responds to light. Small sensors are placed on or near your eyes, and you look at flashing lights while the machine records the electrical signals produced by your retina. This test helps the doctor understand how well the photoreceptor cells in your retina are working. In Stargardt disease, the ERG may show reduced function, particularly in the cone photoreceptors that are responsible for central vision and color perception. A variation called multifocal ERG can test different parts of the retina separately, providing even more detailed information.^[1][7]

Color vision testing is often performed because Stargardt disease can affect your ability to perceive colors accurately. This test involves looking at colored patterns or numbers and identifying what you see. Changes in color vision occur because the disease damages the cone cells in the macula, which are essential for distinguishing different colors.^[1]

Genetic Testing

To confirm a diagnosis of Stargardt disease, your doctor may recommend genetic testing. This involves providing a blood sample or saliva sample, which is sent to a laboratory where specialists examine your DNA. The most common cause of Stargardt disease is a change (mutation) in a gene called ABCA4. This gene provides instructions for making a protein that helps clear away waste material in the retina. When the gene does not work properly, the waste—primarily lipofuscin—builds up and damages the macula.^[1][2]

Genetic testing can identify whether you carry mutations in the ABCA4 gene or, less commonly, in another gene called ELOVL4. Knowing which gene is affected can help confirm the diagnosis and provide important information for family planning, since Stargardt disease is most often inherited in an autosomal recessive pattern. This means that both parents must carry one copy of the mutated gene for their child to develop the condition. Each child of two carrier parents has a 25 percent chance of inheriting both mutated genes and developing Stargardt disease.^[3][7]

Disease Staging

Once Stargardt disease is diagnosed, your eye care specialist may classify how far the disease has progressed using a staging system. In Stage 1, small flecks of lipofuscin have formed in the macula, and symptoms may be mild. By Stage 2, the flecks have spread beyond the macula to surrounding areas of the retina, and symptoms become more noticeable. Stage 3 is marked by the flecks being reabsorbed into the macula, causing damage and thinning of tissue, a process called atrophy. Finally, in Stage 4, the atrophy is severe enough that significant or complete loss of central vision occurs. Understanding what stage you are in helps both you and your doctor plan for what to expect and what support you may need.^[2][9]

Diagnostics for Clinical Trial Qualification

If you are interested in participating in a clinical trial for Stargardt disease, you will need to undergo specific diagnostic tests to determine whether you qualify. Clinical trials are research studies that test new treatments, and they have strict criteria about who can join. These criteria ensure that the study results are meaningful and that participants are as safe as possible during the research.^[1][10]

For enrollment in most Stargardt disease trials, genetic testing is essential. Researchers need to confirm that you have mutations in the ABCA4 gene or another gene linked to Stargardt disease. This genetic confirmation ensures that the trial is studying people with the same underlying cause of vision loss. Some trials may focus on specific types of mutations, so your exact genetic profile can determine whether you are eligible.^[2][22]

Imaging studies such as OCT and fundus autofluorescence are commonly required to assess the extent of retinal damage. Trial coordinators need to know the baseline condition of your macula and retina so they can measure whether the experimental treatment has any effect. These baseline images are repeated during the trial to track changes over time. Some trials also require ERG testing to measure the functional capacity of your retina before treatment begins.^[7][10]

Visual acuity tests, which measure how well you can see letters or symbols on a chart, are another standard requirement. Clinical trials often enroll participants within a specific range of vision loss—for example, people who still have some usable vision but are experiencing significant impairment. This ensures that the trial can detect whether the treatment helps preserve or improve vision.^[4][10]

In addition to these tests, trial participants may need to provide detailed medical histories and undergo general health screenings. Blood tests, physical examinations, and assessments of other body systems may be necessary to ensure that participants do not have conditions that could interfere with the study or put them at risk. For example, some experimental gene therapies or drug treatments may not be suitable for people with certain immune system conditions or other health problems.^[11][15]